Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00646048 · ClinicalTrials.gov registry record · Phase 1
A Phase I Evaluation of the Safety of the TriVascular Stent-Graft System in the Treatment of Abdominal Aortic Aneurysms
A Phase 1 study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
- 43
- Enrollment target
NCT00646048 is a Phase 1 study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 43 participants.
The verdict
NCT00646048, a Phase 1 study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 43 participants
- Enrollment target
Study Summary
This study was a prospective observational study examined the safety of the TriVascular AAA Stent-Graft System in the elective treatment of patients with abdominal aortic aneurysms. Specifically, the study will evaluate the safety of the TriVascualr AAA Stent-Graft System, evaluate the ability to deliver the Tri-Vascular AAA Stent-Graft System to the desired location within the aorta, and evaluate the ability of the TriVascular AAA Stent-Graft to exclude the abdominal aortic aneurysm.
Interventions
- DEVICE TriVascular Stent-Graft System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2003-02 |
| Est. Completion | 2010-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00646048
The ClinicalTrials.gov registry entry for NCT00646048 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TriVascular Stent-Graft System is the first listed.
NCT00646048 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00646048 about?
NCT00646048 is a clinical study titled "A Phase I Evaluation of the Safety of the TriVascular Stent-Graft System in the Treatment of Abdominal Aortic Aneurysms". This study was a prospective observational study examined the safety of the TriVascular AAA Stent-Graft System in the elective treatment of patients with abdominal aortic aneurysms. Specifically, the study will evaluate the safety of the TriVascualr AAA Stent-Graft System, evaluate the ability to de...
What is the current status of trial NCT00646048?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 43 participants. The study started on 2003-02. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00646048?
The interventions under investigation include: TriVascular Stent-Graft System (DEVICE).
Who is sponsoring clinical trial NCT00646048?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.